Ani pharmaceuticals announces initiation of phase 4 clinical trial of purified cortrophin® gel for the treatment of acute gout flares

Purified cortrophin gel is the only acth therapy approved by the fda for the treatment of  acute gout flares trial to be conducted by dr. hyon choi at massachusetts general hospital and will compare the safety and efficacy of two dose levels of purified cortrophin gel for the treatment of acute gout flares princeton, n.j., may 22, 2025 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the initiation of a phase 4 clinical trial at massachusetts general hospital to compare the safety and efficacy of two dose levels (40 usp units and 80 usp units) of purified cortrophin gel (repository corticotropin injection usp) (cortrophin gel) for the treatment of acute gout flares.
ANIP Ratings Summary
ANIP Quant Ranking